Achalasia Cardia

Achalasia Cardia


Achalasia Cardia

  • Achalasia results from damage to nerves in the oesophagus, preventing the oesophagus from squeezing food into the stomach. It may be caused by an abnormal immune system response.
  • Symptoms include a backflow of food in the throat (regurgitation), chest pain and weight loss.
  • Achalasia can usually be managed with minimally invasive (endoscopic) therapy or surgery.
Exam Question
 
  • Mode of treatment for achalasia is associated with high rate of recurrence : Botulinum toxin.
  • Progressive Dysphagia,Regurgitant vomitting  is a presenting problem.
  • Dilated and Tortuous Esophagus is seen in Achalasia Cardia.
  • The cause is degeneration of ganglion cells of auerbach’s myenteric plexus.
  • Treatment includes heller’s cardiomyotomy, forceful dilation by pneumatic balloon, repeated injection botulinum toxins and drugs improving motility of esophagus.
  • Esophagectomy is not a treatment modality for achalasia cardia.
  • Barium swallow shows a dilated esophagus with tapering narrowing in the terminal end of esophagus, described as ‘BIRD BEAK’ appearance.
  • Fluoroscopy shows loss of normal peristalsis in the lower third of the esophagus..
  • Dysphagia equal for both solid and liquid from the very onset suggests motor disorder i.e achalasia and diffuse esophageal spasm.
  • The characteristic esophageal manometry finding in achalasia cardia is Impaired lower esophageal sphincter relaxation and absent peristalsis.
  • It is believed that cause of ganglion cell degeneration in achalasia is an autoimmune process attributable to a latent infection with human herpes simplex virus 1 combined with genetic susceptibility.
  • The malignancy which is a close mimicker of achalasia is Carcinoma of gastric fundus.
  • The most sensitive diagnostic evaluation for achalasia cardia is Esophageal Manometry.

The pharmacologic agents used in Achalasia are:

  1. Nitrates
  2. Calcium channel blockers
  3. Botulinum toxin
  4. Sildenafil- phosphodiesterase inhibitors, effectively decrease LES pressure.
  • In pneumatic dilatation for the treatment of achalasia, the cylindrical balloon dilator is dilated upto 3-4 cm.
  • Achalasia is associated with increased risk of Squamous Cell carcinoma of Esophagus.
  • Uniform dilation of esophagus is seen in Achalasia Cardia.
  • Elevated resting LES tone is seen in Achalasia.
  • A 40-year-old female patient presented with dysphagia to both liquids and solids and regurgitation for 3 months. The dysphagia was non-progressive.Achalasia cardia is the most likely diagnosis.
  • ‘Pencil tip’ deformity is seen in Achalasia Cardia.
  • Heller’s operation treatment of choice in Achalasia Cardia.
  • Radiologic feature suggestive of Achalasia cardia is?   Absence of gastric air bubble  , Air fluid level in mediastinum  ,Sigmoid esophagus.
  • Maximum dilatation of esophagus occurs in Achalasia Cardia.
  • Amyl nitrite inhalation is used to distinguish patients of achalasia from those with pseudoachalasia.
  • Non visualization of gastric fundic bubble with air-fluid level in retrocardiac region suggests Achalasia Cardia.
Don’t Forget to Solve all the previous Year Question asked on Achalasia Cardia

Leave a Reply

Discover more from New

Subscribe now to keep reading and get access to the full archive.

Continue reading

👨‍⚕️
Chat Support